相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal unity of ecology and evolution pathological ecosystem
Weiren Luo
THERANOSTICS (2023)
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity
Wongeun Lee et al.
FRONTIERS IN ONCOLOGY (2022)
A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment
Yeejin Jeon et al.
CANCERS (2022)
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer
Katherine C. Fuh et al.
GYNECOLOGIC ONCOLOGY (2021)
Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels
Marie-Anne Goyette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
Shiyu Mao et al.
ONCOTARGETS AND THERAPY (2020)
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H. Lee et al.
NATURE COMMUNICATIONS (2020)
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka et al.
CANCERS (2020)
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
Yoko Tsukita et al.
MOLECULAR CANCER (2019)
Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression
Marisol Herrera-Rivero et al.
MOLECULAR NEUROBIOLOGY (2019)
Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression
Lingyu Kong et al.
BIOSCIENCE REPORTS (2019)
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Gabriele D'Errico et al.
ONCOGENE (2019)
Gas6 attenuates lipopolysaccharide-induced TNF-α expression and apoptosis in H9C2 cells through NF-κB and MAPK inhibition via the Axl/PI3K/Akt pathway
Mengfang Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma
Seon Min Woo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Increased expression of long noncoding RNA GAS6-AS2 promotes proliferation and inhibits apoptosis of melanoma cells via upregulating GAS6 expression
Li Wen et al.
IUBMB LIFE (2019)
Axl signaling is an important mediator of tumor angiogenesis
Mai Tanaka et al.
Oncotarget (2019)
AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
Stephane Terry et al.
CANCER IMMUNOLOGY RESEARCH (2019)
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma
Alisha Holtzhausen et al.
CANCER IMMUNOLOGY RESEARCH (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
Jing Wei et al.
CELLULAR IMMUNOLOGY (2018)
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Bridget Shafit-Zagardo et al.
PHARMACOLOGY & THERAPEUTICS (2018)
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette et al.
CELL REPORTS (2018)
Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC
Leslie L. Sharp et al.
CANCER RESEARCH (2018)
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions
Sohini Roy et al.
CANCER RESEARCH (2018)
Efferocytosis in the tumor microenvironment
Thomas A. Werfel et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking
Selma Maacha et al.
NEOPLASIA (2018)
Growth arrest-specific gene 6 transfer promotes mesenchymal stem cell survival and cardiac repair under hypoxia and ischemia via enhanced autocrine signaling and paracrine action
Shengshuai Shan et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Kathleen F. Ludwig et al.
CANCER RESEARCH (2018)
Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin
Yanli Jin et al.
CLINICAL CANCER RESEARCH (2017)
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
Mihalis S. Kariolis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers
Kavitha Balaji et al.
MOLECULAR CANCER RESEARCH (2017)
Axl signaling induces development of natural killer cells in vitro and in vivo
Eun-Mi Kim et al.
PROTOPLASMA (2017)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Eleni Vergadi et al.
JOURNAL OF IMMUNOLOGY (2017)
Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+ CD25+ Regulatory T Cells Mainly through Axl Receptor
Guang-ju Zhao et al.
MEDIATORS OF INFLAMMATION (2017)
PI3K/Akt and ERK/MAPK Signaling Promote Different Aspects of Neuron Survival and Axonal Regrowth Following Rat Facial Nerve Axotomy
Haitao Huang et al.
NEUROCHEMICAL RESEARCH (2017)
Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells
Lidia Bosurgi et al.
SCIENCE (2017)
Molecular insights of Gas6/TAM in cancer development and therapy
Guiling Wu et al.
CELL DEATH & DISEASE (2017)
Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
Zhiqiang Guo et al.
ONCOTARGET (2017)
Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses
Laurent Meertens et al.
CELL REPORTS (2017)
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
Pinar Kanlikilicer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer
Triparna Sen et al.
CLINICAL CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase
Todd A. Aguilera et al.
CLINICAL CANCER RESEARCH (2017)
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer
Heath D. Skinner et al.
CLINICAL CANCER RESEARCH (2017)
Giving AXL the axe: targeting AXL in human malignancy
Carl M. Gay et al.
BRITISH JOURNAL OF CANCER (2017)
TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition
D. J. Pinato et al.
ONCOGENE (2016)
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
D. N. Debruyne et al.
ONCOGENE (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2016)
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Mechanosensing Controlled Directly by Tyrosine Kinases
Bo Yang et al.
NANO LETTERS (2016)
Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd A. Aguilera et al.
NATURE COMMUNICATIONS (2016)
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
Min-Shu Hsieh et al.
ONCOTARGET (2016)
Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3 beta/beta-catenin Signaling
Cun Wang et al.
THERANOSTICS (2016)
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
Magdalena Paolino et al.
CANCERS (2016)
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
Caitlin D. May et al.
BMC CANCER (2015)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Toni M. Brand et al.
CLINICAL CANCER RESEARCH (2015)
The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung
T. Fujimori et al.
MUCOSAL IMMUNOLOGY (2015)
Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma
Kuo-Chou Chiu et al.
ORAL ONCOLOGY (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Crosstalk between ERK, AKT, and cell survival
Paul Dent
CANCER BIOLOGY & THERAPY (2014)
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Catherine Wilson et al.
CANCER RESEARCH (2014)
AXL Mediates Resistance to Cetuximab Therapy
Toni M. Brand et al.
CANCER RESEARCH (2014)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
Mihalis S. Kariolis et al.
NATURE CHEMICAL BIOLOGY (2014)
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
S. Ammoun et al.
ONCOGENE (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma
M. A. Cichon et al.
ONCOGENE (2014)
AXL kinase as a novel target for cancer therapy
Xiaoliang Wu et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug
Yunhee Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Molecular Pathways: MERTK Signaling in Cancer
Christopher T. Cummings et al.
CLINICAL CANCER RESEARCH (2013)
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Rebecca S. Cook et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
J. D. Paccez et al.
ONCOGENE (2013)
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
A. B. Lee-Sherick et al.
ONCOGENE (2013)
Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
Jaclyn Sceneay et al.
CANCER RESEARCH (2012)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages
Tingting Deng et al.
IMMUNOLOGY (2012)
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Anjali Mishra et al.
MOLECULAR CANCER RESEARCH (2012)
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Joannes F. M. Jacobs et al.
LANCET ONCOLOGY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
Sonja Loges et al.
BLOOD (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
TAM receptor signaling and autoimmune disease
Carla V. Rothlin et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Sertoli Cell-Initiated Testicular Innate Immune Response through Toll-Like Receptor-3 Activation Is Negatively Regulated by Tyro3, Axl, and Mer Receptors
Bing Sun et al.
ENDOCRINOLOGY (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
Il-Kyoo Park et al.
BLOOD (2009)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Jan-Bart M. Koorstra et al.
CANCER BIOLOGY & THERAPY (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Paradoxical Roles of IL-4 in Tumor Immunity
Zhiguang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives
M. Angela Nieto
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors
D. Mahadevan et al.
ONCOGENE (2007)
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinorna cells expressing AXL
Jong-Ding Lay et al.
CANCER RESEARCH (2007)
Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway
Tateo Sawabu et al.
MOLECULAR CARCINOGENESIS (2007)
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases
Sassan Hafizi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
Anouk Caraux et al.
NATURE IMMUNOLOGY (2006)
Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling
VA Korshunov et al.
CIRCULATION RESEARCH (2006)
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
P Vajkoczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structural basis for Gas6-Axl signalling
T Sasaki et al.
EMBO JOURNAL (2006)
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
K Macleod et al.
CANCER RESEARCH (2005)
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor
PP Sainaghi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Ligand recognition and homophilic interactions in Tyro3 -: Structural insights into the Axl/Tyro3 receptor tyrosine kinase family
C Heiring et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins
MD Huang et al.
NATURE STRUCTURAL BIOLOGY (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase
PL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Identification of Gas6, a putative ligand for sky and Ax1 receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons
H Funakoshi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis
WP Lee et al.
ONCOGENE (2002)
Gas6 induces mesangial cell proliferation via latent transcription factor STAT3
M Yanagita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
A Angelillo-Scherrer et al.
NATURE MEDICINE (2001)
分享论文
